Evaluation and management of hypo-osmolality in hospitalized patients

Endocrinology and Metabolism Clinics of North America

Volumn 32, Issue 2, 2003, Pages 459-481

  Janicic, Natasa ^a   Verbalis, Joseph G ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; DEMECLOCYCLINE; DIURETIC AGENT; GLUCOCORTICOID; HYPERTONIC SOLUTION; ISOTONIC SOLUTION; LITHIUM; POTASSIUM; UREA; VASOPRESSIN RECEPTOR ANTAGONIST;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; EVALUATION; HUMAN; HYPONATREMIA; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PLASMA OSMOLALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SODIUM RESTRICTION; UREMIA; WATER DEPRIVATION; WATER METABOLISM;

ANIMALIA;

EID: 0038320329     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(03)00004-5     Document Type: Review

References (88)

1. Anderson RJ, Chung HM, Kluge R, et al. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Int Med 1985;102:164-8.
2. Verbalis JG. Hyponatremia: epidemiology, pathophysiology, and therapy. Curr Opin Nephrol Hyperten 1993;2:636-52.
3. Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 1986;314:1529-35.
4. Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic cnccphalopathy in menstruant women. Ann Int Med 1992;117:891-7.
5. Sterns RH. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann Int Med 1987;107:656-64.
6. Sterns RH, Cappuccio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994;4:1522-30.
7. Sterns RH, Riggs JE, Schochet Jr SS. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 1986;314:1535-42.
8. Robinson AG. Disorders of antidiuretic hormone secretion. Clin Endocrinol Metab 1985;14:55-88.
9. Knepper MA. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol 1997;272:F3-F12.
10. Robertson GL, Thirst and vasopressin function in normal and disordered states of water balance. J Lab Clin Med 1983;101:351-71.
11. DeVita MV, Gardenswartz MH, Konecky A, et al. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol 1990;34:163-6.
12. Kleinfeld M, Casimir M, Borra S. Hyponatremia as observed in a chronic disease facility. J Am Geriatr Soc 1979;27:156-61.
13. Misra SC, Mansharamani GG. Hyponatremia in elderly hospital in-patients. Brit J Clin Prac 1989;43:295-6.
14. Sorensen IJ, Matzen LE. Serum electrolytes and drug therapy of patients admitted to a geriatric department. Ugeskr Laeger 1993;155:3921-4.
15. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc 1995;43:1410-3.
16. Crowe MJ, Forsling ML, Rolls BJ, et al. Altered water excretion in healthy elderly men. Age Ageing 1987;16:285-93.
17. Clinkingbeard C, Sessions C, Shenker Y. The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism. J Clin Endocrinol Metab 1990;70:582-9.
18. Helderman JH, Vestal RE, Rowe JW, et al. The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: the impact of aging. J Gerontol 1978;33:39-47.
19. Weisberg LS. Pseudohyponatremia: a reappraisal [Review]. Am J Med 1989;86:315-8.
20. Nanji AA. Hyperglycemia-induced hyponatremia: A clinical study to validate a correction factor. Clin Chem 1981;27:1771-3.
21. Spital A. Diuretic-induced hyponatremia. Am J Nephrol 1999;19:447-52.
22. Szatalowicz VL, Miller PD, Lacher JW, et al. Comparative effect of diuretics on renal water excretion in hyponatraemic oedematous disorders. Clin Sci (Lond) 1982;62:235-8.
23. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 1981;70:1163-8.
24. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790-806.
25. Robertson GL, Aycinena P, Zerbe RL. Neurogenic disorders of osmoregulation. Am J Med 1982;72:339-53.
26. Zerbe R, Stropes L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 1980;31:315-27.
27. Johnson BE, Damodaran A, Rushin J, et al. Ectopic production and processing of atrial natriuretic peptide in a small cell lung carcinoma cell line and tumor from a patient with hyponatremia. Cancer 1997;79:35-44.
28. Miller M, Moses AM. Drug-induced state of impaired water excretion. Kidney Int 1976;10:96-103.
29. Liu BA, Mittmann N, Knowles SR, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. Can Med Assoc J 1996;155:519-27.
30. Raphael K, Tokeshi J. Hyponatremia associated with sertraline and fluoxetine: a case report. Hawaii Med J 2002;61:46-7.
31. Wilkinson TJ, Begg EJ, Winter AC, et al. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 1999;47:211-7.
32. Abe T, Takaue Y, Okamoto Y, et al. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children undergoing high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Pediatr Hematol Oncol 1995;12:363-9.
33. Bissett D, Cornford EJ, Sokal M. Hyponatraemia following cisplatin chemotherapy. Acta Oncologica 1989;28:823.
34. Cusick JF, Hagen TC, Findling JW. Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors. N Engl J Med 1984;311:36-8.
35. Olson BR, Gumowski J, Rubino D, et al. Pathophysiology of hyponatremia after transsphenoidal pituitary surgery. J Neurosurg 1997;87:499-507.
36. Tang WW, Kaptein EM, Feinstein EI, et al. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med 1993;94:169-74.
37. Vitting KE, Gardenswartz MH, Zabetakis PM et al. Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA 1990;263:973-8.
38. Hirshberg B, Ben-Yehuda A. The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med 1997;103:270-3.
39. Linas SL, Berl T, Robertson GL, et al. Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. Kidney Int 1980;18:58-67.
40. Curtis RH. Hyponatremia in primary myxedema. Ann Int Med 1956;44:376.
41. Iwasaki Y, Oiso Y, Yamauchi K, et al. Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab 1990;70:534-9.
42. Macaron C, Famuyiwa O. Hyponatremia of hypothyroidism. Appropriate suppression of antidiuretic hormone levels. Arch Int Med 1978;138:820-2.
43. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med 1978;64:613-21.
44. Vieweg WV, Karp BI. Severe hyponatremia in the polydipsia-hyponatremia syndrome. J Clin Psychiatry 1994;55:355-61.
45. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 1988;318:397-403.
46. Bichet DG. Water disturbances in cardiac failure [Review]. Baillieres Clin Endocrinol Metab 1989;3:559-74.
47. Riegger GA, Liebau G, Kochsiek K. Antidiuretic hormone in congestive heart failure. Am J Med 1982;72:49-52.
48. Kim JK, Michel JB, Soubrier F, et al. Arginine vasopressin gene expression in chronic cardiac failure in rats. Kidney Int 1990;38:818-22.
49. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67.
50. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984;310:347-52.
51. Schrier RW, Niederberger M, Weigert A, et al. Peripheral arterial vasodilatation: Determinant of functional spectrum of cirrhosis [Review]. Semin Liver Dis 1994;14:14-22.
52. Porcel A, Diaz F, Rendon P, et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162:323-8.
53. Bichet D, Szatalowicz V, Chaimovitz C, et al. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Int Med 1982;96:413-7.
54. Milionis HJ, Liamis GL, Elisaf MS. The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ 2002;166:1056-62.
55. Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 1976;55:121-9.
56. Daggett P, Deanfield J, Moss F. Neurological aspects of hyponatraemia. Postgrad Med J 1982;58:737-40.
57. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med 1997;102:67-77.
58. Verbalis JG, Mangione MP, Stricker EM. Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology 1991;128:1317-22.
59. Videen JS, Michaelis T, Pinto P, et al. Human cerebral osmolytes during chronic hyponatremia. J Clin Invest 1995;95:788-93.
60. Chung HM, Kluge R, Schrier RW, et al. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987;83:905-8.
61. Schwartz WB, Bennett S, Curelop S, et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957;23:529-42.
62. Fichman MP, Vorherr H, Kleeman CR, et al. Diuretic-induced hyponatremia. Ann Int Med 1971;75:853-63.
63. May ME, Carey RM. Rapid adrenocorticotropic hormone test in practice. Am J Med 1985;79:679-84.
64. Carroll PB, McHenry L, Verbalis JG. Isolated adrenocorticotrophic hormone deficiency presenting as chronic hyponatremia. N Y State J Med 1990;90:210-3.
65. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342:1581-9.
66. Verbalis JG. Hyponatremia and hypoosmolar disorders. In: Greenberg A, editor. Primer on Kidney Diseases. 3rd edition. San Diego: Academic Press; 2001. p. 57-63.
67. Oh MS, Kim HJ, Carroll HJ. Recommendations for treatment of symptomatic hyponatremia. Nephron 1995;70:143-50.
68. Gross P, Reimann D, Neidel J, et al. The treatment of severe hyponatremia. Kidney Int Suppl 1998;64:S6-11.
69. Chung HM, Kluge R, Schrier RW, et al. Postoperative hyponatremia. A prospective study. Arch Int Med 1986;146:333-6.
70. Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women [see comments]. Ann Intern Med 1992;117:891-7.
71. Verbalis JG. The syndrome of inappropriate antidiuretic hormone secretion and other hypoosmolar disorders. In: Schrier RW, editor. Diseases of the Kidney and urinary tract. 7th edition. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2511-48.
72. Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore) 1993;72:359-73.
73. Soupart A, Penninckx R, Stenuit A, et al. Treatment of chronic hyponatremia in rats by intravenous saline: comparison of rate versus magnitude of correction. Kidney Int 1992;41:1662-7.
74. Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int 1991;39:1274-82.
75. Brunner JE, Redmond JM, Haggar AM, et al. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol 1990;27:61-6.
76. Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore) 1993;72:359-73.
77. Bibl D, Lampl C, Gabriel C, et al. Treatment of central pontine myelinolysis with therapeutic plasmapheresis. Lancet 1999;353:1155.
78. Adler S, Verbalis JG, Williams D. Effect of rapid correction of hyponatremia on the blood brain barrier of rats. Brain Res 1995;679:135-43.
79. Baker EA, Tian Y, Adler S, et al. Blood-Brain Barrier Disruption and Complement Activation in the Brain Following Rapid Correction of Chronic Hyponatremia. Exp Neurol 2000;165:221-30.
80. Cheng JC, Zikos D, Skopicki HA, et al. Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction. Am J Med 1990;88:561-6.
81. Decaux G, Waterlot Y, Genette F, et al. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide. N Engl J Med 1981;304:329-30.
82. Forrest Jr JN, Cox M, Hong C, et al. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978;298:173-7.
83. Decaux G, Mols P, Cauchi P, et al. Use of urea for treatment of water retention in hyponatraemic cirrhosis with ascites resistant to diuretics. Brit Med J Clin Res 1985;290:1782-3.
84. Saito T, Ishikawa S, Abe K, et al. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Clin Endocrinol Metab 1997;82:1054-7.
85. Wong LL, Verbalis JG. Vasopressin V2 receptor antagonists. Cardiovasc Res 2001;51:391-402.
86. 2 antagonist OPC-31260 in heart failure in the rat. Am J Physiol 1998;275:H176-82.
87. Inoue T, Ohnishi A, Matsuo A, et al. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis. Clin Pharmacol Ther 1998;63:561-70.
88. Yatsu T, Tomura Y, Tahara A, et al. Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure. Eur J Pharmacol 1999;376:239-46.